Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is an American medical device company that designs, manufactures, and markets robotic-assisted surgical systems, most notably the da Vinci surgical system, generating $10.06 billion in revenue in fiscal 2025. Headquartered in Sunnyvale, California, the company has placed over 11,000 da Vinci systems globally and its surgeons perform more than 3 million procedures annually across general surgery, urology, gynecology, cardiothoracic, and head and neck specialties.

This is a story about an installed-base franchise that has, over three decades, built what may be the widest economic moat in medical technology. Roughly 84% of Intuitive's revenue is recurring — instruments, accessories, and service contracts tied to a growing installed base whose utilization rises each year. The file turns on whether the da Vinci 5 platform cycle can sustain the growth premium the market has priced into the stock, and whether competitive threats outside the United States — particularly in China — represent a valuation risk or a genuine franchise risk.

The debate is not about whether robotic surgery will grow; it is about the slope of that growth, the durability of Intuitive's pricing power, and what multiple a scaled med-tech franchise with a debt-free balance sheet and over $8 billion in cash and investments should command in a world where procedure growth is inevitably decelerating from the post-pandemic catch-up years.